Published in J Bacteriol on May 01, 1995
Conditional stability of the HemA protein (glutamyl-tRNA reductase) regulates heme biosynthesis in Salmonella typhimurium. J Bacteriol (1999) 1.46
Thiamine pyrophosphate (TPP) negatively regulates transcription of some thi genes of Salmonella typhimurium. J Bacteriol (1996) 1.31
Salmonella enterica highly expressed genes are disease specific. Infect Immun (2006) 1.06
Contribution of proton-translocating proteins to the virulence of Salmonella enterica serovars Typhimurium, Gallinarum, and Dublin in chickens and mice. Infect Immun (2003) 1.04
RpoS synthesis is growth rate regulated in Salmonella typhimurium, but its turnover is not dependent on acetyl phosphate synthesis or PTS function. J Bacteriol (1999) 1.00
Analysis of the ArcA regulon in anaerobically grown Salmonella enterica sv. Typhimurium. BMC Microbiol (2011) 0.99
Comparative transcriptomics in Yersinia pestis: a global view of environmental modulation of gene expression. BMC Microbiol (2007) 0.92
Stabilization of a HemA-LacZ hybrid protein against proteolysis during carbon starvation in atp mutants of Salmonella typhimurium. J Bacteriol (1996) 0.86
Genetic analysis of the nuo locus, which encodes the proton-translocating NADH dehydrogenase in Escherichia coli. J Bacteriol (1998) 0.85
Importance of sigma factor mutations in increased triclosan resistance in Salmonella Typhimurium. BMC Microbiol (2015) 0.76
REMap: Operon map of M. tuberculosis based on RNA sequence data. Tuberculosis (Edinb) (2016) 0.75
Protein measurement with the Folin phenol reagent. J Biol Chem (1951) 1743.91
Studies on transformation of Escherichia coli with plasmids. J Mol Biol (1983) 116.81
Improved single and multicopy lac-based cloning vectors for protein and operon fusions. Gene (1987) 24.38
New Tn10 derivatives for transposon mutagenesis and for construction of lacZ operon fusions by transposition. Gene (1984) 17.36
Plasmid insertion mutagenesis and lac gene fusion with mini-mu bacteriophage transposons. J Bacteriol (1984) 12.63
Interposon mutagenesis of soil and water bacteria: a family of DNA fragments designed for in vitro insertional mutagenesis of gram-negative bacteria. Gene (1987) 11.03
Phage P22-mutants with increased or decreased transduction abilities. Mol Gen Genet (1972) 10.34
Replacement and amplification of bacterial genes with sequences altered in vitro. Proc Natl Acad Sci U S A (1983) 6.24
The alternative sigma factor katF (rpoS) regulates Salmonella virulence. Proc Natl Acad Sci U S A (1992) 6.16
Chromosomal transformation of Escherichia coli recD strains with linearized plasmids. J Bacteriol (1989) 5.72
Transport of antibiotics and metabolite analogs by systems under cyclic AMP control: positive selection of Salmonella typhimurium cya and crp mutants. J Bacteriol (1978) 4.91
Transitory cis complementation: a method for providing transposition functions to defective transposons. Genetics (1988) 4.67
Identification and expression of genes narL and narX of the nar (nitrate reductase) locus in Escherichia coli K-12. J Bacteriol (1988) 3.71
Improved vector system for constructing transcriptional fusions that ensures independent translation of lacZ. J Bacteriol (1990) 3.49
Constitutive function of a positively regulated promoter reveals new sequences essential for activity. J Biol Chem (1987) 3.23
Oxygen regulation in Salmonella typhimurium. J Bacteriol (1985) 3.14
The minus 35-recognition region of Escherichia coli sigma 70 is inessential for initiation of transcription at an "extended minus 10" promoter. J Mol Biol (1993) 3.08
The NADH:ubiquinone oxidoreductase (complex I) of respiratory chains. Q Rev Biophys (1992) 3.06
Characterization of Tn10d-Cam: a transposition-defective Tn10 specifying chloramphenicol resistance. Mol Gen Genet (1988) 3.04
Construction of an Escherichia coli K-12 ada deletion by gene replacement in a recD strain reveals a second methyltransferase that repairs alkylated DNA. J Bacteriol (1988) 3.01
A method for constructing single-copy lac fusions in Salmonella typhimurium and its application to the hemA-prfA operon. J Bacteriol (1992) 2.90
Construction of vectors with the p15a replicon, kanamycin resistance, inducible lacZ alpha and pUC18 or pUC19 multiple cloning sites. Nucleic Acids Res (1990) 2.77
Nucleotide sequence coding for the respiratory NADH dehydrogenase of Escherichia coli. UUG initiation codon. Eur J Biochem (1981) 2.73
Mutations in NADH:ubiquinone oxidoreductase of Escherichia coli affect growth on mixed amino acids. J Bacteriol (1994) 2.68
A single regulatory gene integrates control of vitamin B12 synthesis and propanediol degradation. J Bacteriol (1992) 2.56
Directed formation of deletions and duplications using Mud(Ap, lac). Genetics (1985) 2.55
Control of electron flow in Escherichia coli: coordinated transcription of respiratory pathway genes. J Bacteriol (1992) 2.28
FNR-dependent repression of the ndh gene of Escherichia coli and metal ion requirement for FNR-regulated gene expression. Mol Microbiol (1989) 2.15
Cloning, genetic characterization, and nucleotide sequence of the hemA-prfA operon of Salmonella typhimurium. J Bacteriol (1989) 2.08
NADH-ubiquinone oxidoreductases of the Escherichia coli aerobic respiratory chain. Biochemistry (1987) 2.04
The requirement of ArcA and Fnr for peak expression of the cyd operon in Escherichia coli under microaerobic conditions. Mol Gen Genet (1991) 1.91
Energetic efficiency of Escherichia coli: effects of mutations in components of the aerobic respiratory chain. J Bacteriol (1993) 1.90
Adaptation of Escherichia coli to redox environments by gene expression. Mol Microbiol (1993) 1.83
Abstracts of papers presented at the 1980 meetings of the Genetic Society of America. Boulder, Colorado August 18-20, 1980. Genetics (1980) 1.81
Isolation and characterization of a mutant of Salmonella typhimurium deficient in a major deoxyribonucleic acid polymerase activity. J Bacteriol (1973) 1.78
Two global regulatory systems (Crp and Arc) control the cobalamin/propanediol regulon of Salmonella typhimurium. J Bacteriol (1993) 1.71
Translational control of pyrC expression mediated by nucleotide-sensitive selection of transcriptional start sites in Escherichia coli. J Bacteriol (1992) 1.65
Demonstration of separate genetic loci encoding distinct membrane-bound respiratory NADH dehydrogenases in Escherichia coli. J Bacteriol (1993) 1.59
Escherichia coli mutants lacking NADH dehydrogenase I have a competitive disadvantage in stationary phase. J Bacteriol (1993) 1.55
Transport of 5-aminolevulinic acid by the dipeptide permease in Salmonella typhimurium. J Bacteriol (1993) 1.35
Regulation of transcription at the ndh promoter of Escherichia coli by FNR and novel factors. Mol Microbiol (1994) 1.26
Characterization of the respiratory NADH dehydrogenase of Escherichia coli and reconstitution of NADH oxidase in ndh mutant membrane vesicles. Biochemistry (1981) 1.25
D-lactate oxidation and generation of the proton electrochemical gradient in membrane vesicles from Escherichia coli GR19N and in proteoliposomes reconstituted with purified D-lactate dehydrogenase and cytochrome o oxidase. Biochemistry (1986) 1.19
Mutants defective in the energy-conserving NADH dehydrogenase of Salmonella typhimurium identified by a decrease in energy-dependent proteolysis after carbon starvation. Proc Natl Acad Sci U S A (1993) 1.14
Resolution and identification of iron-containing antigens in membrane vesicles from Escherichia coli. Biochemistry (1980) 0.84
Induction and exhaustion of lymphocytic choriomeningitis virus-specific cytotoxic T lymphocytes visualized using soluble tetrameric major histocompatibility complex class I-peptide complexes. J Exp Med (1998) 5.78
DsrA RNA regulates translation of RpoS message by an anti-antisense mechanism, independent of its action as an antisilencer of transcription. Proc Natl Acad Sci U S A (1998) 4.99
Glycosylation and the immune system. Science (2001) 4.39
Defining a bacteriophage T4 late promoter: absence of a "-35" region. Cell (1984) 4.16
Assembly of MHC class I molecules analyzed in vitro. Cell (1990) 3.77
Packaging specific segments of the Salmonella chromosome with locked-in Mud-P22 prophages. Genetics (1988) 3.33
Efficient translation of the RpoS sigma factor in Salmonella typhimurium requires host factor I, an RNA-binding protein encoded by the hfq gene. J Bacteriol (1996) 3.04
Mutations that increase expression of the rpoS gene and decrease its dependence on hfq function in Salmonella typhimurium. J Bacteriol (1997) 2.36
A comparison of the costs of ceftazidime therapy and gentamicin combinations in three UK hospitals. J Antimicrob Chemother (1992) 2.28
A phase I/II study of the safety and pharmacokinetics of nevirapine in HIV-1-infected pregnant Ugandan women and their neonates (HIVNET 006). AIDS (1999) 2.23
Assembly and function of the two ABC transporter proteins encoded in the human major histocompatibility complex. Nature (1992) 2.12
NIDDM in the elderly. Diabetes Care (1996) 1.84
Evaluation of a 2% chlorhexidine gluconate in 70% isopropyl alcohol skin disinfectant. J Hosp Infect (2005) 1.78
Breakthrough pain characteristics and syndromes in patients with cancer pain. An international survey. Palliat Med (2004) 1.71
Phosphorylation and metabolism of the transforming protein of Rous sarcoma virus. J Virol (1982) 1.60
The genes required for heme synthesis in Salmonella typhimurium include those encoding alternative functions for aerobic and anaerobic coproporphyrinogen oxidation. J Bacteriol (1992) 1.56
The binding affinity and dissociation rates of peptides for class I major histocompatibility complex molecules. Eur J Immunol (1991) 1.49
IFN-beta mediates coordinate expression of antigen-processing genes in RSV-infected pulmonary epithelial cells. Am J Physiol Lung Cell Mol Physiol (2001) 1.49
Plasmodium falciparum strains from Papua New Guinea: culture characteristics and drug sensitivity. Southeast Asian J Trop Med Public Health (1980) 1.46
Conditional stability of the HemA protein (glutamyl-tRNA reductase) regulates heme biosynthesis in Salmonella typhimurium. J Bacteriol (1999) 1.46
Report on the early efficacy and tolerability of I(125) permanent prostate brachytherapy from a UK multi-institutional database. Clin Oncol (R Coll Radiol) (2008) 1.44
Candida infective endocarditis. Eur J Clin Microbiol Infect Dis (2008) 1.41
Antibiotic prophylaxis for full-face laser resurfacing: is it necessary? Arch Dermatol (2001) 1.39
Naturally processed HLA class II peptides reveal highly conserved immunogenic flanking region sequence preferences that reflect antigen processing rather than peptide-MHC interactions. J Immunol (2001) 1.34
Carbapenem-resistant Acinetobacter and role of curtains in an outbreak in intensive care units. J Hosp Infect (2002) 1.31
Recognition of carbohydrate by major histocompatibility complex class I-restricted, glycopeptide-specific cytotoxic T lymphocytes. J Exp Med (1994) 1.30
Purification of mature schizonts of Plasmodium falciparum on colloidal silica gradients. Bull World Health Organ (1982) 1.30
ECM overrides DNA damage-induced cell cycle arrest and apoptosis in small-cell lung cancer cells through beta1 integrin-dependent activation of PI3-kinase. Cell Death Differ (2006) 1.30
The major component of IkappaBalpha proteolysis occurs independently of the proteasome pathway in respiratory syncytial virus-infected pulmonary epithelial cells. J Virol (1998) 1.28
Promoter substitution and deletion analysis of upstream region required for rpoS translational regulation. J Bacteriol (1998) 1.25
Multiple antigen-specific processing pathways for activating naive CD8+ T cells in vivo. J Immunol (2001) 1.25
Evidence for successive peptide binding and quality control stages during MHC class I assembly. Curr Biol (1998) 1.19
Point mutations in the alpha 2 domain of HLA-A2.1 define a functionally relevant interaction with TAP. Curr Biol (1996) 1.19
Phosphorylated peptides can be transported by TAP molecules, presented by class I MHC molecules, and recognized by phosphopeptide-specific CTL. J Immunol (1999) 1.19
The cell biology of MHC class I antigen presentation. Tissue Antigens (2002) 1.18
A method to quantify binding of unlabeled peptides to class I MHC molecules and detect their allele specificity. J Immunol Methods (1993) 1.14
Mutants defective in the energy-conserving NADH dehydrogenase of Salmonella typhimurium identified by a decrease in energy-dependent proteolysis after carbon starvation. Proc Natl Acad Sci U S A (1993) 1.14
Initiation of transcription at phage T4 late promoters with purified RNA polymerase. Cell (1983) 1.13
An oxygen-dependent coproporphyrinogen oxidase encoded by the hemF gene of Salmonella typhimurium. J Bacteriol (1993) 1.12
Crystal structures of two H-2Db/glycopeptide complexes suggest a molecular basis for CTL cross-reactivity. Immunity (1999) 1.12
Characterization of two Epstein-Barr virus epitopes restricted by HLA-B7. Eur J Immunol (1995) 1.10
Cloning, DNA sequence, and complementation analysis of the Salmonella typhimurium hemN gene encoding a putative oxygen-independent coproporphyrinogen III oxidase. J Bacteriol (1994) 1.10
Phase II trial of docetaxel, cisplatin and 5FU chemotherapy in locally advanced and metastatic penis cancer (CRUK/09/001). Br J Cancer (2013) 1.08
The human HLA-A*0201 allele, expressed in hamster cells, is not a high-affinity receptor for adenovirus type 5 fiber. J Virol (1999) 1.06
Presentation of cytosolic glycosylated peptides by human class I major histocompatibility complex molecules in vivo. J Exp Med (1999) 1.05
Photodynamic therapy with topical methyl aminolaevulinate for 'difficult-to-treat' basal cell carcinoma. Br J Dermatol (2005) 1.03
A quantitative assay of peptide-dependent class I assembly. Eur J Immunol (1991) 1.02
Sexuality and genetic identity in the Agaricus section Arvenses. Appl Environ Microbiol (2000) 1.01
The cell biology of major histocompatibility complex class I assembly: towards a molecular understanding. Tissue Antigens (2010) 1.00
RpoS synthesis is growth rate regulated in Salmonella typhimurium, but its turnover is not dependent on acetyl phosphate synthesis or PTS function. J Bacteriol (1999) 1.00
Poor correspondence between predicted and experimental binding of peptides to class I MHC molecules. Tissue Antigens (2000) 1.00
Genes encoded in the major histocompatibility complex affecting the generation of peptides for TAP transport. Eur J Immunol (1995) 0.99
DNA fusion vaccine designed to induce cytotoxic T cell responses against defined peptide motifs: implications for cancer vaccines. J Immunol (2001) 0.97
Long-term outcome of using allopurinol co-therapy as a strategy for overcoming thiopurine hepatotoxicity in treating inflammatory bowel disease. Aliment Pharmacol Ther (2008) 0.96
Peptide anchor residue glycosylation: effect on class I major histocompatibility complex binding and cytotoxic T lymphocyte recognition. Eur J Immunol (1995) 0.95
A mutant HemA protein with positive charge close to the N terminus is stabilized against heme-regulated proteolysis in Salmonella typhimurium. J Bacteriol (1999) 0.95
Transcription of the glutamyl-tRNA reductase (hemA) gene in Salmonella typhimurium and Escherichia coli: role of the hemA P1 promoter and the arcA gene product. J Bacteriol (1996) 0.94
Metabolic alterations in middle-aged and elderly obese patients with type 2 diabetes. Diabetes Care (1999) 0.92
Anaerobic protoporphyrin biosynthesis does not require incorporation of methyl groups from methionine. J Bacteriol (1995) 0.92
The quantity of naturally processed peptides stably bound by HLA-A*0201 is significantly reduced in the absence of tapasin. Tissue Antigens (2001) 0.92
Hypoglycemia induced by hydroxychloroquine in a type II diabetic treated for polyarthritis. J Rheumatol (1999) 0.91
Multiple lipoprotein abnormalities in type I diabetic patients with renal disease. Diabetes (1996) 0.91
Developmental outcomes in children receiving resection surgery for medically intractable infantile spasms. Dev Med Child Neurol (1997) 0.90
The complex pattern of transcription in the segment of the bacteriophage T4 genome containing three of the head protein genes. Virology (1984) 0.90
HLA-A*0201 presents TAP-dependent peptide epitopes to cytotoxic T lymphocytes in the absence of tapasin. Eur J Immunol (1998) 0.89
Regulation of heme biosynthesis in Salmonella typhimurium: activity of glutamyl-tRNA reductase (HemA) is greatly elevated during heme limitation by a mechanism which increases abundance of the protein. J Bacteriol (1997) 0.88
An assay for peptide binding to HLA-Cw*0102. Tissue Antigens (1999) 0.87
AZD3514, an oral selective androgen receptor down-regulator in patients with castration-resistant prostate cancer - results of two parallel first-in-human phase I studies. Invest New Drugs (2015) 0.87
Stabilization of a HemA-LacZ hybrid protein against proteolysis during carbon starvation in atp mutants of Salmonella typhimurium. J Bacteriol (1996) 0.86
Serum procalcitonin, interleukin-6, soluble intercellular adhesin molecule-1 and IgG to short-chain exocellular lipoteichoic acid as predictors of infection in total joint prosthesis revision. Br J Biomed Sci (2010) 0.86
A soluble major histocompatibility complex class I peptide-binding platform undergoes a conformational change in response to peptide epitopes. J Biol Chem (1998) 0.85
What is the significance of a positive Propionibacterium acnes culture around a joint replacement? Int Orthop (2008) 0.85
Association of the human invariant chain with H-2 Db class I molecules. Eur J Immunol (1992) 0.84
Antigen presentation. Naturally processed peptides. Nature (1990) 0.84
Smoking is a major risk factor for anastomotic leak in patients undergoing low anterior resection. Colorectal Dis (2012) 0.83
A blinded pilot comparison of capsule endoscopy and small bowel histology in unresponsive celiac disease. Dig Dis Sci (2008) 0.83
An immunodominant MHC class II-restricted tumor antigen is conformation dependent and binds to the endoplasmic reticulum chaperone, calreticulin. J Immunol (2001) 0.83
Generation of a functional, soluble tapasin protein from an alternatively spliced mRNA. Genes Immun (2004) 0.82
Identification of novel Tapasin polymorphisms and linkage disequilibrium to MHC class I alleles. Immunogenetics (2000) 0.82
Routine intracranial pressure monitoring in acute coma. Cochrane Database Syst Rev (2001) 0.81
Alterations in non-insulin-mediated glucose uptake in the elderly patient with diabetes. Diabetes (1998) 0.81
Lectin purified human class I MHC-derived peptides: evidence for presentation of glycopeptides in vivo. Tissue Antigens (2000) 0.81
N(G)-monomethyl-L-arginine alters insulin-mediated calf blood flow but not glucose disposal in the elderly. Metabolism (2001) 0.80
Glucocorticoid-induced hyperglycemia is prevalent and unpredictable for patients undergoing cancer therapy: an observational cohort study. Curr Oncol (2013) 0.79
Central venous catheters and infection. Use of antimicrobial catheters needs to undergo trials. BMJ (1998) 0.79
Glycan-regulated antigen processing of a protein in the endoplasmic reticulum can uncover cryptic cytotoxic T cell epitopes. J Exp Med (1998) 0.77
Plasma cholesteryl ester transfer protein and its relationship to plasma lipoproteins and apolipoprotein A-I-containing lipoproteins in IDDM patients with microalbuminuria and clinical nephropathy. Diabetes Care (1994) 0.77
Regulation of apolipoprotein A-I-containing lipoproteins in IDDM. Diabetes (1993) 0.77
Beta-lactam-dependent coagulase-negative staphylococcus associated with urinary-tract infection. Lancet (1999) 0.77
An improved assembly assay for peptide binding to HLA-B*2705 and H-2K(k) class I MHC molecules. J Immunol Methods (1997) 0.77
Regulation of transcription in the segment of the bacteriophage T4 genome containing three of the head protein genes: plasmid-specific and phage chromosome-specific effects. Virology (1984) 0.76
A review of 24 cases of Mohs surgery and ophthalmic plastic reconstruction. Aust N Z J Ophthalmol (1997) 0.76
A novel serological test for the laboratory diagnosis of central venous catheter-associated sepsis. J Antimicrob Chemother (2000) 0.75
Tapping into tumours. Nat Genet (1996) 0.75
Comparison of combination chemotherapy programs in advanced adenocarcinoma-large cell carcinoma of the lung: a North Central Cancer Treatment Group study. Cancer Treat Rep (1984) 0.75
Two rare unstable beta chain variants, Hb Mozhaisk or alpha 2 beta 292(F8)His----Arg and Hb Djelfa or alpha 2 beta 298(Fg5)Val----Ala, each being observed for the second time. Hemoglobin (1989) 0.75
Haemoglobin M-Hyde Park associated with polyagglutinable red blood cells in a South African family. Br J Haematol (1988) 0.75
MHC-restricted T cell responses against posttranslationally modified peptide antigens. Adv Immunol (2001) 0.75
General anesthesia in sickle cell disease. S Afr Med J (1989) 0.75
Can a transitional work grant program in a workers' compensation system reduce cost and facilitate return to work? J Occup Environ Hyg (2008) 0.75